tiprankstipranks
Trending News
More News >
MiNK Therapeutics (INKT)
NASDAQ:INKT
US Market

MiNK Therapeutics (INKT) Income Statement

Compare
251 Followers

MiNK Therapeutics Income Statement

Last quarter (Q3 2025), MiNK Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, MiNK Therapeutics's net income was $-2.89M. See MiNK Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -215.44K$ -204.62K$ -121.75K$ -77.96K$ -55.06K
Operating Expenses
$ 10.43M$ 22.72M$ 30.83M$ 18.53M$ 10.74M
Depreciation and Amortization
$ 215.44K$ 204.62K$ 121.75K$ 77.96K$ 55.06K
EBITDA
$ -10.57M$ -22.25M$ -27.87M$ -27.70M$ -13.74M
Operating Income
$ -10.65M$ -22.92M$ -30.95M$ -18.61M$ -10.80M
Other Income/Expenses
$ -134.56K$ 463.25K$ 2.96M$ -11.61M$ -5.44M
Pretax Income
$ -10.78M$ -22.46M$ -27.99M$ -30.21M$ -16.24M
Net Income
$ -10.78M$ -22.46M$ -27.99M$ -30.21M$ -16.24M
Per Share Metrics
Basic EPS
$ -2.90$ -6.54$ -8.31$ -9.03$ -4.91
Diluted EPS
$ -2.80$ -6.54$ -8.31$ -9.03$ -4.91
Weighted Average Shares Outstanding
3.74M 3.44M 3.37M 3.35M 3.31M
Weighted Average Shares Outstanding (Diluted)
3.86M 3.44M 3.37M 3.35M 3.31M
Currency in USD

MiNK Therapeutics Earnings and Revenue History